SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-038597
Filing Date
2023-06-20
Accepted
2023-06-20 18:36:10
Documents
1
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3872
  Complete submission text file 0001209191-23-038597.txt   5357
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 5AM VENTURES 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address
Allison David D. (Reporting) CIK: 0001853903 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 231026889